Monday, April 24, 2017 8:59:21 PM
PTI has 85 million in cash and a collaboration with Astellas for UPR Modulators worth up to $400 million in milestone payments, CF pipeline with PTI 428 and triple combination could be worth a fortune with good clinical results. MC is ridiculously low at this price IMHO.
The results of PTI 428 WITH 8 CF patients are due this quarter. If the results are good then the stock will sail. Also, good results will probably lead to TDN endorsement which will cause a bigger bounce. Results could be released any time in the 2Q.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM